Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility

Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility

Source: 
Medical Marketing and Media
snippet: 


Moderna has chosen Oxfordshire, England as the location for its U.K. Innovation and Technology Centre (MITC), which is expected to open in 2025. The pharma’s new mRNA manufacturing facility will be based at the Harwell Science and Innovation Campus.